Glucose-6-phosphate dehydrogenase deficiency and risk of diabetes: A systematic review and meta-analysis

Yin Key Lai, Nai Ming Lai, Shaun Wen Huey Lee

    Research output: Contribution to journalReview ArticleResearchpeer-review

    14 Citations (Scopus)


    Emerging epidemiological evidence suggests that patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency may have a higher risk of developing diabetes. The aim of the review was to synthesise the evidence on the association between G6PD deficiency and diabetes. A systematic search on Medline, EMBASE, AMED and CENTRAL databases for studies published between January 1966 and September 2016 that assessed the association between G6PD deficiency and diabetes was conducted. This was supplemented by a review of the reference list of retrieved articles. We extracted data on study characteristics, outcomes and performed an assessment on the methodological quality of the studies. A random-effects model was used to compute the summary risk estimates. Fifteen relevant publications involving 949,260 participants were identified, from which seven studies contributed to the meta-analysis. G6PD deficiency was associated with a higher odd of diabetes (odds ratio 2.37, 95% confidence interval 1.50–3.73). The odds ratio of diabetes among men was higher (2.22, 1.31–3.75) compared to women (1.87, 1.12–3.12). This association was broadly consistent in the sensitivity analysis. Current evidence suggests that G6PD deficiency may be a risk factor for diabetes, with higher odds among men compared to women. Further research is needed to determine how G6PD deficiency moderates diabetes.

    Original languageEnglish
    Pages (from-to)839-845
    Number of pages7
    JournalAnnals of Hematology
    Issue number5
    Publication statusPublished - May 2017


    • Diabetes
    • Gender
    • Glucose-6-phosphate dehydrogenase deficiency
    • Prevalence

    Cite this